key: cord-0745518-kv8wze1u
authors: Santos, Lígia Rodrigues; Lopes, Rafaela Gonçalves; Rocha, Ana Silva; Martins, Marta Dalila; Guimarães, Teresa C.; Meireles, Mariana; Vilaça, Helena; Castro, Alice; Mesquita, Mari
title: Outcomes of COVID-19 patients treated with noninvasive respiratory support outside-ICU setting: a Portuguese reality
date: 2021-10-02
journal: Pulmonology
DOI: 10.1016/j.pulmoe.2021.09.002
sha: ddf0095add9c25d2d71413f8d46dc6132f57ca4c
doc_id: 745518
cord_uid: kv8wze1u

nan

Noninvasive respiratory support (NRS) has become a valuable tool in COVID-19 acute respiratory failure (ARF) management. However, there is a lack of consensus in for or against its use due to the risks of intubation delay and aerosols environmental contamination. 1 Strategies to mitigate NRS iatrogenic risks and healthcare workers infection have been suggested. 2, 3 Despite efforts to increase ICU resources, to cope with patient influx, general wards worldwide were converted in respiratory intermediate care units (RICU) , where patients in need for NRS were treated. 4, 5 Our goal was to evaluate the Portuguese reality regarding safeness and outcomes of NRS in COVID-19

ARF in a non-ICU setting. , supporting strategy safeness.

In-hospital mortality was 36.6%, higher than in other series. 5, 7, 8 It is important to note that, in our sample, ARF was severe and almost 50% were DNI patients. Interestingly, 41% of DNI patients survived hospitalization supporting the role of NRS in patients with therapeutic ceiling.

We report a success rate of 62% in HFNC group, with a survival greater than 50% in DNI patients. In CPAP/NIV treatment group, success was achieved in 30%. Patients in this group were older, had more severe ARF and 71% were DNI. Mortality rates in patients treated outside-ICU, in whom NIV was the therapeutic ceiling, reached 76% in previously reports, which is in line with our findings. 6, 7, 9 Nevertheless, CPAP/NIV prevented IMV in 40% of the candidates, with mortality rates similar to published data. 10 The difference in ETI and mortality rates between groups disappeared after adjustment for confounders, emphasising that outcomes don't rely on the NRS technique. Complications were infrequent. Pneumothorax/pneumomediastinum is reported in 2% of ICU treated patients. 11 Barotrauma occurred in both groups equally after adjustment for confounders, suggesting that underling disease severity might play a role.

Our study has limitations: the decision to start on a specific NRS technique greatly relied on equipment availability and is single-centered with a limited sample.

To the best of our knowledge this is the first prospective study on NRS outside-ICU in COVID-19

pneumonia, conducted in one of the Portuguese regions that was most affected. Both HFNC and CPAP/NIV seem to be equally feasible and outside-ICU should be considered for selected patients in resource-constrained settings.

The authors declare that they have no conflict of interests. Data are presented as number (percentages) or mean (standard deviation) as appropriate. HFNC: high flow nasal cannula; CPAP: continuous positive airway pressure; NIV: noninvasive ventilation; ETI: endotracheal intubation. # adjusted for age, arterial oxygen tension/inspiratory oxygen fraction ratio and "do not intubate" order. ¶ adjusted for age and arterial oxygen tension/inspiratory oxygen fraction ratio.

Noninvasive respiratory support in acute hypoxemic respiratory failure associated with COVID-19 and other viral infections

COVID-19 pandemic and noninvasive respiratory management: Every Goliath needs a David. An evidence based evaluation of problems. Pulmonology

Medical masks and Respirators for the Protection of Healthcare Workers from SARS-CoV-2 and other viruses

The utility of high-flow nasal oxygen for severe COVID-19 pneumonia in a resource-constrained setting: A multi-centre prospective observational study

Feasibility and clinical impact of out-of-ICU noninvasive respiratory support in patients with COVID-19-related pneumonia

Effectiveness and safety of noninvasive positive pressure ventilation in the treatment of COVID-19-associated acute hypoxemic respiratory failure: a single center, non-ICU setting experience

Noninvasive Ventilatory Support of Patients with COVID-19 outside the Intensive Care Units

High-flow nasal oxygen: a safe, efficient treatment for COVID-19 patients not in an ICU

Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak

Safety Assessment of a Noninvasive Respiratory Protocol for Adults With COVID-19

COVID-19 and pneumothorax: a multicentre retrospective case series

We would like to thank all healthcare professionals that have been working in RICU during this pandemic.We would also like to thank the ICU team for all the support provided.